billHR10272Event Thursday, September 3, 2026Analyzed

To amend the Controlled Substances Act to schedule MGM-15 and MGM-16 as Schedule I Controlled substances, and to amend the controlled Substances Act to schedule synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl, as a Schedule I above a specific threshold under the Controlled Substances Act, and to expand enforcement actions against drug manufacturers and distributors of emerging synthetic opioids, commonly known as gas station heroin.

Bearish

Summary

HR10272, introduced by Rep. Gooden, would schedule specific synthetic opioids as Schedule I controlled substances and expand enforcement against manufacturers and distributors of emerging synthetic opioids known as gas station heroin. However, the bill is in very early legislative stages with no cosponsors and no appropriation, and no major pharmaceutical company has material exposure to these substances.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.HR10272 is an early-stage scheduling bill with no cosponsors, no funding, and no direct revenue impact on major healthcare companies.
  • 2.The targeted substances are synthetic opioids sold outside legitimate pharmaceutical supply chains, not products of JNJ or ZTS.
  • 3.Legislative momentum is minimal; the bill faces a long path through two committees and the full House and Senate.

Market Implications

The bill does not affect revenue of any major publicly traded healthcare or pharmaceutical company. No concrete market implications for JNJ (FY2025 rev $85.2B) or ZTS. The only potential impact is a broad regulatory tailwind for enforcement agencies, but no ticker-linked financial consequence is identifiable.

Full Analysis

On 2026-09-03, Rep. Lance Gooden (R-TX) introduced HR10272, a bill to amend the Controlled Substances Act to add MGM-15, MGM-16, synthetic 7-hydroxymitragynine, and Mitragynine Pseudoindoxyl to Schedule I, and to expand enforcement against makers and distributors of certain synthetic opioids. The bill was referred to the House Energy and Commerce and Judiciary Committees. It has no cosponsors. The bill authorizes no funding—it is purely a scheduling and enforcement measure. No major pharmaceutical company has revenue tied to these specific synthetic opioids. Companies like JNJ focus on regulated pain management products and do not operate in the gas station heroin space. The legislative path is long: committee markups, potential floor votes, Senate consideration, and presidential signature. Given early stage and lack of financial impact on publicly traded entities, the bill is low impact. Convergence with other anti-opioid legislation could strengthen enforcement mechanisms, but no related signals are present.

Key Legislators

Rep. Gooden, Lance [R-TX-5]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderSep 4, 2026

Promoting Fair Competition In Livestock Markets And Expanding Market Access for American Meat Producers

This executive order directs the USDA to aggressively enforce the Packers and Stockyards Act against large meat packers, increase investigations and staffing, and coordinate with the DOJ on antitrust actions. It also aims to expand interstate market access for small processors by streamlining cooperative inspection programs, modernizing inspection rules, and creating a loan program for small and regional beef processors.

Exec OrderAug 26, 2026

Declaring a National Emergency to Secure the United States Bulk-Power System

This executive order declares a national emergency to restrict foreign-produced bulk-power system electric equipment that poses national security risks, prohibiting new transactions involving equipment from covered foreign entities and allowing the Secretary of Energy to impose conditions on existing equipment. It directs the Secretary of Energy, in coordination with multiple agencies, to identify, mitigate, and potentially replace risky equipment, and establishes a pre-qualification list for approved vendors.

proclamationAug 19, 2026

Temporary Suspension of Additional Duties to Offset Canadian Discrimination Against the Commerce of the United States with Respect to Alcoholic Beverages, Dairy, and Motor Vehicles

This proclamation postpones the effective date of previously imposed additional ad valorem duties (up to 50%) on Canadian imports of alcoholic beverages, dairy, and motor vehicles—originally set for August 19, 2026—to August 22, 2026, citing Canada's commitment to remove discriminatory practices. It uses authority under Section 338 of the Tariff Act of 1930, Section 604 of the Trade Act of 1974, and directs U.S. Customs and Border Protection and other agencies to suspend collection and implement refunds as needed.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →